Pharmaceutical applications of affinity-ultrafiltration mass spectrometry: Recent advances and future prospects.

The immunoaffinity of protein with ligand is broadly involved in many bioanalytical methods. Affinity-ultrafiltration mass spectrometry (AUF-MS), a platform based on interaction of protein-ligand affinity, has been developed to fish out interesting molecules from complex matrixes. Here we reviewed the basics of AUF-MS and its recent applications to pharmaceutical field, i.e. target-oriented discovery of lead compounds from combinatorial libraries and natural product extracts, and determination of free drug concentration in biosamples. Selected practical examples were highlighted to illustrate the advances of AUF-MS in pharmaceutical fields. The future prospects were also presented.

[1]  Lian‐Wen Qi,et al.  Mass spectrometry-based strategies for screening of bioactive natural products. , 2011, Combinatorial chemistry & high throughput screening.

[2]  G. Kovacs,et al.  A validated method for measurement of serum total, serum free, and salivary cortisol, using high-performance liquid chromatography coupled with high-resolutionESI-TOF mass spectrometry , 2014, Analytical and Bioanalytical Chemistry.

[3]  Yuankai Shi,et al.  Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasma. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  Yang Song,et al.  Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery , 2011, Nucleic Acids Res..

[5]  Bin Wu,et al.  A strategy for screening of high-quality enzyme inhibitors from herbal medicines based on ultrafiltration LC-MS and in silico molecular docking. , 2015, Chemical communications.

[6]  Hui Zhang,et al.  Screening and determination for potential α-glucosidase inhibitory constituents from Dalbergia odorifera T. Chen using ultrafiltration-LC/ESI-MS(n). , 2013, Biomedical chromatography : BMC.

[7]  Shuying Liu,et al.  SCREENING FOR α-GLUCOSIDASE INHIBITORS FROM COPTIDIS-REHMANNIAE HERB COUPLE BY USING ULTRAFILTRATION LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY , 2012 .

[8]  C. Jeleazcov,et al.  Determination of total and unbound sufentanil in human plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetic study. , 2012, Journal of pharmaceutical and biomedical analysis.

[9]  Shu Liu,et al.  Screening and determination for potential α-glucosidase inhibitors from leaves of Acanthopanax senticosus harms by using UF-LC/MS and ESI-MS(n). , 2012, Phytochemical analysis : PCA.

[10]  Xu Zhou,et al.  Screening of minor bioactive compounds from herbal medicines by in silico docking and the trace peak exposure methods. , 2016, Journal of chromatography. A.

[11]  J. Henion,et al.  Immunoaffinity Ultrafiltration with Ion Spray HPLC/MS for Screening Small-Molecule Libraries. , 1997, Analytical chemistry.

[12]  Xiaoqing Chen,et al.  Analysis of tyrosinase binders from Glycyrrhiza uralensis root: evaluation and comparison of tyrosinase immobilized magnetic fishing-HPLC and reverse ultrafiltration-HPLC. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Tao Jiang,et al.  Screening for potential -α -Glucosidase inhibitors in Coptis chinensis franch extract using ultrafiltration LC-ESI-MSn. , 2014, Pakistan journal of pharmaceutical sciences.

[14]  E. Begg,et al.  Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS. , 2011, Bioanalysis.

[15]  William Fenical,et al.  Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS. , 2011, Analytical chemistry.

[16]  D. Musson,et al.  Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  J. Navarro,et al.  Darunavir and Ritonavir Total and Unbound Plasmatic Concentrations in HIV-HCV-Coinfected Patients with Hepatic Cirrhosis Compared to Those in HIV-Monoinfected Patients , 2015, Antimicrobial Agents and Chemotherapy.

[18]  C. Manetti,et al.  Analysis of Bile Acids Profile in Human Serum by Ultrafiltration Clean-up and LC-MS/MS , 2012, Chromatographia.

[19]  Jeroen Kool,et al.  Recent developments in protein–ligand affinity mass spectrometry , 2010, Analytical and bioanalytical chemistry.

[20]  G. Terstappen,et al.  Target deconvolution strategies in drug discovery , 2007, Nature Reviews Drug Discovery.

[21]  C. Jeleazcov,et al.  Determination of total and unbound propofol in patients during intensive care sedation by ultrafiltration and LC-MS/MS. , 2016, Journal of pharmaceutical and biomedical analysis.

[22]  V. Kaushik,et al.  Mass spectrometric techniques for label-free high-throughput screening in drug discovery. , 2007, Analytical chemistry.

[23]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[24]  R. Tubiana,et al.  Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  F. M. Musteata Monitoring free drug concentrations: challenges. , 2011, Bioanalysis.

[26]  F. D. Boudinot,et al.  Measurement and Analysis of Unbound Drug Concentrations , 1996, Clinical pharmacokinetics.

[27]  Yujung Jung,et al.  Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS , 2015, Molecules.

[28]  P. Zufferey,et al.  Quantification of total and unbound tranexamic acid in human plasma by ultrafiltration liquid chromatography/tandem mass spectrometry: application to pharmacokinetic analysis. , 2014, Journal of pharmaceutical and biomedical analysis.

[29]  P. Gandia,et al.  Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC-MS/MS assay and ultrafiltration method. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  J. Pezzuto,et al.  Evaluation of cyclooxygenase-2 inhibitors using pulsed ultrafiltration mass spectrometry. , 2000, Analytical chemistry.

[31]  K. Brown,et al.  Ultrafiltration in serum protein binding determinations. , 1981, Journal of pharmaceutical sciences.

[32]  J. Bolton,et al.  Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors , 2005, Journal of the American Society for Mass Spectrometry.

[33]  M. Marzinke,et al.  Bioanalytical development and validation of liquid chromatographic–tandem mass spectrometric methods for the quantification of total and free cefazolin in human plasma and cord blood , 2015, Practical laboratory medicine.

[34]  Shu Liu,et al.  Rapid screening and detection of XOD inhibitors from S. tamariscina by ultrafiltration LC-PDA–ESI-MS combined with HPCCC , 2014, Analytical and Bioanalytical Chemistry.

[35]  R. V. van Breemen,et al.  Applications of pulsed ultrafiltration-mass spectrometry. , 2002, Mass spectrometry reviews.

[36]  G. Deng,et al.  Applications of mass spectrometry in early stages of target based drug discovery. , 2006, Journal of pharmaceutical and biomedical analysis.

[37]  Shu Liu,et al.  Screening and determination of potential xanthine oxidase inhibitors from Radix Salviae Miltiorrhizae using ultrafiltration liquid chromatography-mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[38]  P. Tulkens,et al.  Validation of a HPLC-MS/MS assay for the determination of total and unbound concentration of temocillin in human serum. , 2015, Clinical biochemistry.

[39]  S. Shi,et al.  Identification of major α-glucosidase inhibitors in Radix Astragali and its human microsomal metabolites using ultrafiltration HPLC-DAD-MS(n.). , 2015, Journal of pharmaceutical and biomedical analysis.

[40]  Jin Xie,et al.  Application of the ultrafiltration-based LC-MS approach for screening PTP1B inhibitors from Chinese red yeast rice , 2016 .

[41]  Yiyu Cheng,et al.  Hollow fiber based affinity selection combined with high performance liquid chromatography-mass spectroscopy for rapid screening lipase inhibitors from lotus leaf. , 2013, Analytica chimica acta.

[42]  Lingyi Kong,et al.  Determination of α-glucosidase inhibitors from Scutellaria baicalensis using liquid chromatography with quadrupole time of flight tandem mass spectrometry coupled with centrifugal ultrafiltration. , 2015, Chinese journal of natural medicines.

[43]  Dong Yang,et al.  The screening of potential α-glucosidase inhibitors from the Polygonum multiflorum extract using ultrafiltration combined with liquid chromatography-tandem mass spectrometry , 2014 .

[44]  Shu Liu,et al.  Screening and structural characterization of potential α-glucosidase inhibitors from Radix Astragali flavonoids extract by ultrafiltration LC-DAD-ESI-MSn , 2015 .

[45]  Richard B van Breemen,et al.  Screening drugs for metabolic stability using pulsed ultrafiltration mass spectrometry. , 2002, Combinatorial chemistry & high throughput screening.

[46]  Minmin Zhang,et al.  Rapid screening, identification, and purification of neuraminidase inhibitors from Lithospermum erythrorhizon Sieb.et Zucc. by ultrafiltration with HPLC-ESI-TOF-MS combined with semipreparative HPLC. , 2016, Journal of separation science.

[47]  Ni Ai,et al.  Rapid screening natural-origin lipase inhibitors from hypolipidemic decoctions by ultrafiltration combined with liquid chromatography-mass spectrometry. , 2015, Journal of pharmaceutical and biomedical analysis.

[48]  Shu Liu,et al.  Characterization of compounds and potential neuraminidase inhibitors from the n-butanol extract of Compound Indigowoad Root Granule using ultrafiltration and liquid chromatography-tandem mass spectrometry. , 2012, Journal of pharmaceutical and biomedical analysis.

[49]  M. Ziebell,et al.  Affinity selection-mass spectrometry screening techniques for small molecule drug discovery. , 2007, Current opinion in chemical biology.

[50]  Henk Lingeman,et al.  Mass spectrometry-based biochemical assays for enzyme-inhibitor screening , 2007 .

[51]  Jürgen Bajorath,et al.  Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.

[52]  R. V. van Breemen,et al.  Pulsed ultrafiltration mass spectrometry: a new method for screening combinatorial libraries. , 1997, Analytical chemistry.

[53]  G. Lauretti,et al.  Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[54]  Wenkui Li,et al.  Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). , 2011, Fitoterapia.

[55]  Yu-Ping Zhang,et al.  Combination of preparative HPLC and HSCCC methods to separate phosphodiesterase inhibitors from Eucommia ulmoides bark guided by ultrafiltration-based ligand screening , 2013, Analytical and Bioanalytical Chemistry.

[56]  E. Begg,et al.  Quantification of total and free concentrations of R- and S-warfarin in human plasma by ultrafiltration and LC-MS/MS , 2011, Analytical and Bioanalytical Chemistry.

[57]  Jing Li,et al.  Development of a method to screen and isolate potential xanthine oxidase inhibitors from Panax japlcus var via ultrafiltration liquid chromatography combined with counter-current chromatography. , 2015, Talanta.

[58]  Rong Tsao,et al.  Ultrafiltration LC-ESI-MSn screening of 5-lipoxygenase inhibitors from selected Chinese medicinal herbs Saposhnikovia divaricata, Smilax glabra, Pueraria lobata and Carthamus tinctorius , 2016 .

[59]  Quan Wang,et al.  Multiple ligand detection and affinity measurement by ultrafiltration and mass spectrometry analysis applied to fragment mixture screening. , 2015, Analytica chimica acta.

[60]  K. Schug,et al.  Natural Product Drug Discovery and Analysis Using Mass Spectrometry and Affinity-Based Technologies , 2014 .

[61]  Shu Liu,et al.  Ultrafiltration LC-PDA-ESI/MS combined with reverse phase-medium pressure liquid chromatography for screening and isolation potential α-glucosidase inhibitors from Scutellaria baicalensis Georgi , 2014 .

[62]  Feng Xu,et al.  Development of a mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method for screening mitochondria-targeted bioactive constituents from complex matrixes: Herbal medicines as a case study. , 2015, Journal of chromatography. A.

[63]  Hao Cai,et al.  Ultrafiltration coupled with high-performance liquid chromatography and quadrupole-time-of-flight mass spectrometry for screening lipase binders from different extracts of Dendrobium officinale , 2015, Analytical and Bioanalytical Chemistry.

[64]  Yuchi Zhang,et al.  Development of a method to screen and isolate potential α-glucosidase inhibitors from Panax japonicus C.A. Meyer by ultrafiltration, liquid chromatography, and counter-current chromatography. , 2015, Journal of separation science.

[65]  C. Jeleazcov,et al.  Analysis of total and unbound hydromorphone in human plasma by ultrafiltration and LC-MS/MS: application to clinical trial in patients undergoing open heart surgery. , 2012, Journal of pharmaceutical and biomedical analysis.

[66]  Minmin Zhang,et al.  An in vitro AChE inhibition assay combined with UF-HPLC-ESI-Q-TOF/MS approach for screening and characterizing of AChE inhibitors from roots of Coptis chinensis Franch. , 2016, Journal of pharmaceutical and biomedical analysis.

[67]  R. Tsao,et al.  Ultrafiltration LC-ESI-MSn screening of MMP-2 inhibitors from selected Chinese medicinal herbs Smilax glabra Roxb., Smilax china L. and Saposhnikovia divaricata (Turcz.) Schischk as potential functional food ingredients , 2015 .

[68]  J. D. Elliott,et al.  Drug discovery in the next millennium. , 2000, Annual review of pharmacology and toxicology.

[69]  F. Tse,et al.  Developing a robust ultrafiltration-LC-MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[70]  Richard B. van Breemen,et al.  Screening for Ligands of Human Retinoid X Receptor-α Using Ultrafiltration Mass Spectrometry , 2007 .

[71]  Shu Liu,et al.  Bioactivity fingerprint analysis of cyclooxygenase-2 ligands from radix Aconiti by ultrafiltration–UPLC–MSn , 2013, Analytical and Bioanalytical Chemistry.

[72]  Yu Guo,et al.  Identification of inhibitors of the antibiotic-resistance target New Delhi metallo-β-lactamase 1 by both nanoelectrospray ionization mass spectrometry and ultrafiltration liquid chromatography/mass spectrometry approaches. , 2013, Analytical chemistry.

[73]  A. Calderón,et al.  Screening of natural compounds for ligands to PfTrxR by ultrafiltration and LC-MS based binding assay. , 2011, Journal of pharmaceutical and biomedical analysis.

[74]  A. Calderón,et al.  Identification of oleamide in Guatteria recurvisepala by LC/MS-based Plasmodium falciparum thioredoxin reductase ligand binding method. , 2011, Planta medica.

[75]  Rong Tsao,et al.  SCREENING AND STRUCTURAL CHARACTERIZATION OF MMP-2 INHIBITOR FROM CARTHAMUS TINCTORIUS L. USING ULTRAFILTRATION LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY , 2014 .

[76]  Jun Chen,et al.  Screening for selective inhibitors of xanthine oxidase from Flos Chrysanthemum using ultrafiltration LC-MS combined with enzyme channel blocking. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[77]  Yi Wang,et al.  An ultrafiltration high-performance liquid chromatography coupled with diode array detector and mass spectrometry approach for screening and characterising tyrosinase inhibitors from mulberry leaves. , 2012, Analytica chimica acta.